RE: Immunocidin Marketing Partner Exactly Handle.....
Who cares if Immunocidin has full regulatory approval in a multi-billion dollar market that vets will be crawling over themselves to sell (given they can't sell the existing option, chemo, right now).
Short bus dwellers like plovie/mercedes et al would have you believe that the immunocidin stuff is background noise, but it is the single most important product until the Urocidin uptick starts late this year early next and is a $5-7 add-on to the SP by itself.....and it has full approval....this isn't fluff......
The only thing required to make the market believe in the $5 effect is a partner with deep pockets and broad sales force. That will come before the year-end Conf Call to be sure......
This ain't no bluechip IBM or GE where the market waits for confirmation of earnings to reset the SP, this is a pure spec play that will move with leaps and bounds on news....and with all the irons in the fire right now, even if one of the 4-5 irons comes up empty, we're still in the money with a 10-20 bagger near to medium term on halo effect alone......
Patience will be richly rewarded...and don't forget about the new Chair....he ain't an M&A guru for nothing